Search research articles
Contact Us
Filters
Showing results (151-160 of 315) with videos related to
Page
of 32
Sort By:
British Journal of Cancer
|
August 23, 2017
RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses
Saoirse O Dolly, Mark D Gurden, Konstantinos Drosopoulos, et al.
Cancer Research
|
February 27, 2009
Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells
Nathalie Gaspar, Swee Y Sharp, Simon Pacey, et al.
Cancer Research
|
March 13, 2020
CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells
Rebecca F Rogers, Michael I Walton, Daniel L Cherry, et al.
Cell Cycle (Georgetown, Tex.)
|
December 14, 2007
The cyclin-dependent kinase inhibitor seliciclib (R-roscovitine; CYC202) decreases the expression of mitotic control genes and prevents entry into mitosis
Steven R Whittaker, Robert H Te Poele, Florence Chan, et al.
Cancer Research
|
April 19, 2005
Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition
Mounia Beloueche-Babari, L Elizabeth Jackson, Nada M S Al-Saffar, et al.
Bioorganic & Medicinal Chemistry
|
March 24, 2009
The identification of novel PLC-gamma inhibitors using virtual high throughput screening
Jóhannes Reynisson, William Court, Ciaran O'Neill, et al.
Oncotarget
|
November 5, 2013
Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX
Marissa V Powers, Melanie Valenti, Susana Miranda, et al.
Journal of Biomolecular Screening
|
August 12, 2006
Identification of small-molecule inhibitors of protein kinase B (PKB/AKT) in an AlphaScreenTM high-throughput screen
Samantha Burns, Jonathan Travers, Ian Collins, et al.
Molecular Cancer Therapeutics
|
May 12, 2010
Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma
Nathalie Gaspar, Swee Y Sharp, Suzanne A Eccles, et al.
Blood
|
May 26, 2007
Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells
Emma L Davenport, Hannah E Moore, Alan S Dunlop, et al.
Page
of 32
Search research articles
Search
Showing results (151-160 of 315) with videos related to
Sort By:
Page
of 32
British Journal of Cancer
|
August 23, 2017
RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses
Saoirse O Dolly, Mark D Gurden, Konstantinos Drosopoulos, et al.
Cancer Research
|
February 27, 2009
Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells
Nathalie Gaspar, Swee Y Sharp, Simon Pacey, et al.
Cancer Research
|
March 13, 2020
CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells
Rebecca F Rogers, Michael I Walton, Daniel L Cherry, et al.
Cell Cycle (Georgetown, Tex.)
|
December 14, 2007
The cyclin-dependent kinase inhibitor seliciclib (R-roscovitine; CYC202) decreases the expression of mitotic control genes and prevents entry into mitosis
Steven R Whittaker, Robert H Te Poele, Florence Chan, et al.
Cancer Research
|
April 19, 2005
Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition
Mounia Beloueche-Babari, L Elizabeth Jackson, Nada M S Al-Saffar, et al.
Bioorganic & Medicinal Chemistry
|
March 24, 2009
The identification of novel PLC-gamma inhibitors using virtual high throughput screening
Jóhannes Reynisson, William Court, Ciaran O'Neill, et al.
Oncotarget
|
November 5, 2013
Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX
Marissa V Powers, Melanie Valenti, Susana Miranda, et al.
Journal of Biomolecular Screening
|
August 12, 2006
Identification of small-molecule inhibitors of protein kinase B (PKB/AKT) in an AlphaScreenTM high-throughput screen
Samantha Burns, Jonathan Travers, Ian Collins, et al.
Molecular Cancer Therapeutics
|
May 12, 2010
Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma
Nathalie Gaspar, Swee Y Sharp, Suzanne A Eccles, et al.
Blood
|
May 26, 2007
Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells
Emma L Davenport, Hannah E Moore, Alan S Dunlop, et al.
Page
of 32